HEADER HYDROLASE 24-JUN-09 2WLQ TITLE NUCLEOPHILE-DISABLED LAM16A MUTANT HOLDS LAMINARIHEPTAOSE (L7) IN A TITLE 2 CYCLICAL CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE LAMINARINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 21-318; COMPND 5 SYNONYM: LAMINARINASE 16A; COMPND 6 EC: 3.2.1.6; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PHANEROCHAETE CHRYSOSPORIUM; SOURCE 3 ORGANISM_TAXID: 5306; SOURCE 4 STRAIN: K-3; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPICZALPHAA KEYWDS LAMINARIN, FAMILY 16, CYCLICAL POYSACCHARIDES, GLYCOSYL HYDROLASE, KEYWDS 2 BETA SANDWICH, BASIDIOMYCETE, BETA-GLUCANASE, GH7, GH16, LAM16A, KEYWDS 3 BETA-1\, 6-GLUCAN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.VASUR,R.KAWAI,E.ANDERSSON,G.WIDMALM,K.H.JONSSON,H.HANSSON, AUTHOR 2 A.ENGSTROM,K.IGARASHI,M.SANDGREN,M.SAMEJIMA,J.STAHLBERG REVDAT 8 20-NOV-24 2WLQ 1 REMARK REVDAT 7 13-DEC-23 2WLQ 1 HETSYN LINK REVDAT 6 29-JUL-20 2WLQ 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 08-MAY-19 2WLQ 1 REMARK REVDAT 4 08-NOV-17 2WLQ 1 COMPND REMARK HET HETNAM REVDAT 4 2 1 FORMUL HELIX SHEET LINK REVDAT 4 3 1 SITE ATOM REVDAT 3 12-JUL-17 2WLQ 1 REVDAT 2 21-SEP-11 2WLQ 1 JRNL REMARK VERSN REVDAT 1 26-JAN-10 2WLQ 0 JRNL AUTH J.VASUR,R.KAWAI,K.H.JONSSON,G.WIDMALM,A.ENGSTROM,M.FRANK, JRNL AUTH 2 E.ANDERSSON,H.HANSSON,Z.FORSBERG,K.IGARASHI,M.SAMEJIMA, JRNL AUTH 3 M.SANDGREN,J.STAHLBERG JRNL TITL SYNTHESIS OF CYCLIC BETA-GLUCAN USING LAMINARINASE 16A JRNL TITL 2 GLYCOSYNTHASE MUTANT FROM THE BASIDIOMYCETE PHANEROCHAETE JRNL TITL 3 CHRYSOSPORIUM. JRNL REF J.AM.CHEM.SOC. V. 132 1724 2010 JRNL REFN ISSN 0002-7863 JRNL PMID 20078120 JRNL DOI 10.1021/JA909129B REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : RESTRAINED REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 56165 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 2851 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3791 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.24 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE SET COUNT : 227 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2244 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 161 REMARK 3 SOLVENT ATOMS : 363 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.063 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.064 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2564 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3554 ; 1.615 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 305 ; 6.648 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 115 ;37.486 ;24.609 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 300 ;10.593 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;17.745 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 430 ; 0.145 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1922 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1192 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1819 ; 0.321 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 272 ; 0.119 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 39 ; 0.229 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 30 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1502 ; 0.842 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2420 ; 1.482 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1062 ; 1.965 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1134 ; 2.950 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2WLQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1290038069. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-SEP-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.983 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR (DCM) REMARK 200 OPTICS : COLLIMATOR AND FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56288 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 23.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SCALA REMARK 200 STARTING MODEL: PDB ENTRY 2CL2 REMARK 200 REMARK 200 REMARK: RIGID BODY REFINEMENT WITH LAM16A APO STRUCTURE PDB 2CL2 REMARK 200 AS MODEL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8 MG/ML PROTEIN SOLUTION IN 10 MM REMARK 280 NAOAC WAS MIXED WITH AN EQUAL VOLUME OF CRYSTALLIZATION BUFFER REMARK 280 CONTAINING 20% PEG 3350, 0.2 M AMMONIUM NITRATE AND 10 MM SODIUM REMARK 280 ACETATE BUFFER, PH 5.0, AT 20 DEGREES. SOAKING: 24 H IN 5 MM REMARK 280 LAMINAROHEPTASACCHARIDE. CRYOPROTECTANT CONTAINED 35 % (W/V) PEG REMARK 280 3350, 0.2 M AMMONIUM NITRATE AND 10 MM SODIUM ACETATE BUFFER, PH REMARK 280 5.0, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.13650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.95500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.13650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.95500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU 135 TO SER REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 81 -94.19 -114.68 REMARK 500 THR A 151 -84.41 -103.89 REMARK 500 CYS A 236 119.94 -160.24 REMARK 500 ASP A 243 -153.74 -115.32 REMARK 500 CYS A 254 -131.53 53.81 REMARK 500 TRP A 257 -65.84 -102.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 LAMINARIHEPTAOSE, A BETA-1-3-LINKED GLUCAN REMARK 600 FROM LAMINARIA DIGITATA, HAS BEEN ASSIGNED CHAIN B. REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 650 SECONDARY STRUCTURE ASSIGNED BY DSSP REMARK 650 DSSP OUTPUT CONVERTED BY DSSP2PDB VERSION 0.03 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 THE FOLLOWING SHEET RECORDS FOR MODEL `1` CHAIN ID `A` REMARK 700 HAVE BEEN DETERMINED BY BETA-SPIDER, VERSION ALPHA 2.0 REMARK 700 WITH AN ENERGY THRESHOLD OF -8.2 KCAL/MOL REMARK 700 USING COULOMB ELECTROSTATICS REMARK 700 USING 12-6 L-J VAN DER WAALS REMARK 700 USING BETA-SPIDER RULE SETS. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2W39 RELATED DB: PDB REMARK 900 GLC(BETA-1-3)GLC DISACCHARIDE IN -1 AND -2 SITES OF LAMINARINASE REMARK 900 16A FROM PHANEROCHAETE CHRYSOSPORIUM REMARK 900 RELATED ID: 2W52 RELATED DB: PDB REMARK 900 2 BETA-GLUCANS (6-O-GLUCOSYL-LAMINARITRIOSE ) IN BOTH DONOR AND REMARK 900 ACCEPTOR SITES OF GH16 LAMINARINASE 16A FROM PHANEROCHAETE REMARK 900 CHRYSOSPORIUM. REMARK 900 RELATED ID: 2CL2 RELATED DB: PDB REMARK 900 ENDO-1,3(4)-BETA-GLUCANASE FROM PHANEROCHAETE CHRYSOSPORIUM, SOLVED REMARK 900 USING NATIVE SULFUR SAD, EXHIBITING INTACT HEPTASACCHARIDE REMARK 900 GLYCOSYLATION REMARK 900 RELATED ID: 2WNE RELATED DB: PDB REMARK 900 MUTANT LAMINARINASE 16A CYCLIZES LAMINARIHEPTAOSE REMARK 999 REMARK 999 SEQUENCE REMARK 999 POINT MUTATION OF NUCLEOPHILE RESIDUE GLUTAMATE 115 TO REMARK 999 SERINE (THIS IS A E115S MUTANT) DBREF 2WLQ A 1 298 UNP Q874E3 Q874E3_PHACH 21 318 SEQADV 2WLQ SER A 115 UNP Q874E3 GLU 135 ENGINEERED MUTATION SEQRES 1 A 298 ALA THR TYR HIS LEU GLU ASP ASN TRP VAL GLY SER ALA SEQRES 2 A 298 PHE LEU SER THR PHE THR HIS GLU ALA ILE ALA ASP PRO SEQRES 3 A 298 THR HIS GLY ARG VAL ASN TYR VAL ASP GLN ALA THR ALA SEQRES 4 A 298 LEU ALA LYS ASN LEU THR TYR ALA SER GLY ASP THR LEU SEQRES 5 A 298 ILE LEU ARG ALA ASP HIS THR THR THR LEU SER PRO SER SEQRES 6 A 298 GLY PRO GLY ARG ASN SER VAL ARG ILE ARG SER ILE LYS SEQRES 7 A 298 THR TYR THR THR HIS VAL ALA VAL PHE ASP VAL ARG HIS SEQRES 8 A 298 MET PRO GLN GLY CYS GLY THR TRP PRO ALA ALA TRP GLU SEQRES 9 A 298 THR ASP GLU GLY ASP TRP PRO ASN GLY GLY SER VAL ASP SEQRES 10 A 298 ILE ILE GLU GLY VAL ASN ASP GLN SER PRO ASN ALA MET SEQRES 11 A 298 THR LEU HIS THR GLY ALA ASN CYS ALA MET PRO ALA SER SEQRES 12 A 298 ARG THR MET THR GLY HIS ALA THR ASN ASN ASN CYS ASP SEQRES 13 A 298 VAL ASN THR ASP GLY ASN THR GLY CYS GLY VAL GLN ALA SEQRES 14 A 298 PRO THR ALA ASN SER TYR GLY PRO SER PHE ASN ALA ASN SEQRES 15 A 298 GLY GLY GLY TRP TYR ALA MET GLU ARG THR ASN SER PHE SEQRES 16 A 298 ILE LYS VAL TRP PHE PHE PRO ARG ASN ALA GLY ASN VAL SEQRES 17 A 298 PRO ASN ASP ILE ALA SER GLY PRO ALA THR ILE ASN THR SEQRES 18 A 298 ASP ASN TRP GLY THR PRO THR ALA PHE PHE PRO ASN THR SEQRES 19 A 298 ASN CYS ASP ILE GLY SER HIS PHE ASP ALA ASN ASN ILE SEQRES 20 A 298 ILE ILE ASN LEU THR PHE CYS GLY ASP TRP ALA GLY GLN SEQRES 21 A 298 ALA SER ILE PHE ASN GLY ALA GLY CYS PRO GLY SER CYS SEQRES 22 A 298 VAL ASP TYR VAL ASN ASN ASN PRO SER ALA PHE ALA ASN SEQRES 23 A 298 ALA TYR TRP ASP ILE ALA SER VAL ARG VAL TYR GLN HET NAG B 1 28 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET MAN B 5 11 HET MAN B 6 11 HET MAN B 7 11 HET BGC C 1 12 HET BGC C 2 11 HET BGC C 3 22 HET BGC C 4 11 HET BGC C 5 11 HET BGC C 6 22 HET BGC C 7 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM BGC BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 MAN 4(C6 H12 O6) FORMUL 3 BGC 7(C6 H12 O6) FORMUL 4 HOH *363(H2 O) HELIX 1 AA1 VAL A 10 SER A 12 5 3 HELIX 2 AA2 ALA A 13 THR A 17 1 5 HELIX 3 AA3 ASP A 35 LYS A 42 1 8 HELIX 4 AA4 GLU A 107 TRP A 110 5 4 HELIX 5 AA5 THR A 171 SER A 174 5 4 HELIX 6 AA6 TYR A 175 ASN A 182 1 8 HELIX 7 AA7 PRO A 209 SER A 214 1 6 HELIX 8 AA8 ASP A 222 TRP A 224 5 3 HELIX 9 AA9 ASP A 237 PHE A 242 1 6 HELIX 10 AB1 CYS A 254 GLY A 259 1 6 HELIX 11 AB2 GLN A 260 ALA A 267 1 8 HELIX 12 AB3 SER A 272 ASN A 280 1 9 HELIX 13 AB4 PRO A 281 ALA A 285 5 5 SHEET 1 AA1 5 THR A 45 SER A 48 0 SHEET 2 AA1 5 THR A 51 ARG A 55 -1 O ILE A 53 N TYR A 46 SHEET 3 AA1 5 TYR A 288 TYR A 297 -1 O TRP A 289 N LEU A 54 SHEET 4 AA1 5 THR A 2 TRP A 9 -1 N GLU A 6 O VAL A 296 SHEET 5 AA1 5 THR A 218 ASN A 220 -1 O ILE A 219 N TYR A 3 SHEET 1 AA2 7 THR A 45 SER A 48 0 SHEET 2 AA2 7 THR A 51 ARG A 55 -1 O ILE A 53 N TYR A 46 SHEET 3 AA2 7 TYR A 288 TYR A 297 -1 O TRP A 289 N LEU A 54 SHEET 4 AA2 7 HIS A 83 HIS A 91 -1 N VAL A 86 O ARG A 295 SHEET 5 AA2 7 GLY A 185 ARG A 191 -1 O TYR A 187 N PHE A 87 SHEET 6 AA2 7 PHE A 195 PRO A 202 -1 O PHE A 201 N TRP A 186 SHEET 7 AA2 7 ALA A 229 PRO A 232 -1 O PHE A 231 N ILE A 196 SHEET 1 AA3 8 PHE A 18 HIS A 20 0 SHEET 2 AA3 8 ARG A 73 SER A 76 -1 O ARG A 75 N THR A 19 SHEET 3 AA3 8 ASN A 246 PHE A 253 -1 O ILE A 249 N ILE A 74 SHEET 4 AA3 8 THR A 98 THR A 105 -1 N TRP A 103 O ILE A 248 SHEET 5 AA3 8 SER A 115 GLU A 120 -1 O ILE A 118 N ALA A 102 SHEET 6 AA3 8 ALA A 129 HIS A 133 -1 O THR A 131 N ASP A 117 SHEET 7 AA3 8 CYS A 165 GLN A 168 -1 O VAL A 167 N MET A 130 SHEET 8 AA3 8 HIS A 149 ALA A 150 -1 N HIS A 149 O GLN A 168 SHEET 1 AA4 2 VAL A 31 TYR A 33 0 SHEET 2 AA4 2 ARG A 69 SER A 71 1 O ARG A 69 N ASN A 32 SSBOND 1 CYS A 96 CYS A 269 1555 1555 2.14 SSBOND 2 CYS A 138 CYS A 236 1555 1555 2.04 SSBOND 3 CYS A 155 CYS A 165 1555 1555 2.03 SSBOND 4 CYS A 254 CYS A 273 1555 1555 2.09 LINK ND2 ASN A 43 C1 ANAG B 1 1555 1555 1.45 LINK ND2 ASN A 43 C1 BNAG B 1 1555 1555 1.45 LINK O4 ANAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 BNAG B 1 C1 NAG B 2 1555 1555 1.43 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.44 LINK O6 BMA B 3 C1 MAN B 4 1555 1555 1.44 LINK O6 MAN B 4 C1 MAN B 5 1555 1555 1.43 LINK O3 MAN B 4 C1 MAN B 7 1555 1555 1.43 LINK O2 MAN B 5 C1 MAN B 6 1555 1555 1.44 LINK O3 BGC C 1 C1 BGC C 2 1555 1555 1.44 LINK O3 BGC C 2 C1 ABGC C 3 1555 1555 1.42 LINK O3 BGC C 2 C1 BBGC C 3 1555 1555 1.42 LINK O3 ABGC C 3 C1 BGC C 4 1555 1555 1.44 LINK O3 BBGC C 3 C1 BGC C 4 1555 1555 1.44 LINK O3 BGC C 4 C1 BGC C 5 1555 1555 1.44 LINK O3 BGC C 5 C1 ABGC C 6 1555 1555 1.44 LINK O3 BGC C 5 C1 BBGC C 6 1555 1555 1.44 LINK O3 ABGC C 6 C1 BGC C 7 1555 1555 1.43 LINK O3 BBGC C 6 C1 BGC C 7 1555 1555 1.43 CISPEP 1 TRP A 110 PRO A 111 0 3.07 CISPEP 2 SER A 126 PRO A 127 0 0.23 CRYST1 38.273 47.910 152.400 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026128 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020872 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006562 0.00000